• "One a penny, two a penny", I saw the hot cross bun sign"
• 20S proteasome enhancers prevent cytotoxic tubulin polymerization-promoting protein induced α-synuclein aggregation
• A multiverse of α-synuclein: investigation of prion strain properties with carboxyl-terminal truncation specific antibodies in animal models
• A Patient with Multiple System Atrophy-Parkinsonian Type Presenting with Progressive Micrographia
• A Potent Sybody Selectively Inhibits α-Synuclein Amyloid Formation by Binding to the P1 Region
• A rapidly progressive multiple system atrophy-cerebellar variant model presenting marked glial reactions with inflammation and spreading of alpha-synuclein oligomers and phosphorylated alpha-synuclein aggregates
• Advance care planning in multiple system atrophy: ethical challenges and considerations
• Ageing-related tau astrogliopathy severely affecting the substantia nigra
• An update on multiple system atrophy
• Analysis and occurrence of biallelic pathogenic repeat expansions in RFC1 in a German cohort of patients with a main clinical phenotype of motor neuron disease
• Aptamer binding footprints discriminate α-synuclein fibrillar polymorphs from different synucleinopathies
• Assessing serum anti-nuclear antibodies HEp-2 patterns in synucleinopathies
• Association of dysphagia severity in multiple system atrophy with the specific binding ratio on dopamine transporter SPECT
• Association study of GBA1 variants with MSA based on comprehensive sequence analysis -Pitfalls in short-read sequence analysis depending on the human reference genome
• Beyond the hippocampus: Amygdala and memory functioning in older adults
• Binding adaptability of chemical ligands to polymorphic α-synuclein amyloid fibrils
• Brain and the whole-body bone imaging appearances in Menkes disease: a case report and literature review
• Brain MRI Volumetric Assessment of Patients With Multiple Sclerosis: The Volume of Basal Ganglia, Thalamus, and Posterior Fossa
• Brain Proteome Profiling Reveals Common and Divergent Signatures in Parkinson's Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy
• Burden of rare genetic disorders in India: twenty-two years' experience of a tertiary centre
• Case Report and Literature Review: Orthostatic Hypotension Due to Multiple System Atrophy
• Cerebellar form of multiple system atrophy: A case report
• Cerebrospinal fluid concentration gradients of catechols in synucleinopathies
• Changes in PI3K/AKT and NRF2/HO-1 signaling expression and intestinal microbiota in bleomycin-induced pulmonary fibrosis
• Changes in PI3K/AKT and NRF2/HO-1signaling expression and intestinal microbiota in bleomycin-induced pulmonary fibrosis
• China's Modified Version of Sniffin' Sticks 12-Identification Test Used in Chinese Parkinson's Disease and Multiple System Patients: Comparison of Three Olfactory Testing Methods
• Clinical Application of 18F-THK5351 PET to Image Ongoing Astrogliosis in MSA-P and MSA-C
• Clinical characteristics and phenoconversion in isolated REM sleep behavior disorder: a prospective single-center study in Korea, compared with Montreal cohort
• Combining salivary alpha-synuclein seeding activity and miRNA-29a to distinguish Parkinson's disease and multiple system atrophy
• Computer-Based Evaluation of alpha-Synuclein Pathology in Multiple System Atrophy as a Novel Tool to Recognize Disease Subtypes
• Computer-based evaluation of alpha-synuclein pathology in multiple system atrophy as a novel tool to recognize disease-subtypes
• Convention vs. Innovation II: Skin biopsy for synuclein inclusions will replace dopamine transporter imaging for Parkinson disease diagnosis
• Correction for Prusiner et al., Evidence for alpha-synuclein prions causing multiple system atrophy in humans with parkinsonism
• Corrigendum to "Pilot therapeutic education program in multiple system atrophy: Safety, quality of life and satisfaction from a national registry based longitudinal study" [Park. Relat. Disord. (2024) 106993]
• Current understanding of cardiovascular autonomic dysfunction in multiple sclerosis
• Data-Driven Subtypes of Multiple System Atrophy and Their Implications for Prognosis
• Deep brain stimulation and suicide attempts in treatment-resistant patients: a case report and neuroethical analysis
• Determinants of care partner burden in atypical Parkinsonian syndromes: A retrospective, multi-center analysis
• Different neurotoxicity and seeding activity between alpha-synuclein oligomers formed in plasma of patients with Parkinson's disease and multiple system atrophy
• Differential diagnosis value of sympathetic skin response and cutaneous silent period on early-stage multiple system atrophy and Parkinson disease
• Distinct patterns of electrophysiologic-neuroimaging correlations between Parkinson's disease and multiple system atrophy
• Distinctive Pattern of Metal Deposition in Neurologic Wilson Disease: Insights From 7T Susceptibility-Weighted Imaging
• DNA methylation patterns in the frontal lobe white matter of multiple system atrophy, Parkinson's disease, and progressive supranuclear palsy: a cross-comparative investigation
• Dynamics of peripheral T cell exhaustion and monocyte subpopulations in neurocognitive impairment and brain atrophy in chronic HIV infection
• Dysregulation of cerebrospinal fluid metabolism profiles in spinal muscular atrophy patients: a case control study
• Early-onset dysphagia predicts short survival in multiple system atrophy
• End-of-life care in multiple system atrophy: UK survey of patients and families
• Evolving insights into erythrocytes in synucleinopathies
• Extracellular vesicles from bodily fluids for the accurate diagnosis of Parkinson's disease and related disorders: A systematic review and diagnostic meta-analysis
• Genes associated with multiple system atrophy
• Genetic profiles of multiple system atrophy revealed by exome sequencing, long-read sequencing and spinocerebellar ataxia repeat expansion analysis
• Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia
• Human organoid model of pontocerebellar hypoplasia 2a recapitulates brain region-specific size differences
• Imaging α-synuclein pathologies in animal models and patients with Parkinson's and related diseases
• Impact of Magnetic Resonance Imaging Markers on the Diagnostic Performance of the International Parkinson and Movement Disorder Society Multiple System Atrophy Criteria
• Interaction between α-Synuclein and Bioactive Lipids: Neurodegeneration, Disease Biomarkers and Emerging Therapies
• Intranasal administration of trehalose reduces α-synuclein oligomers and accelerates α-synuclein aggregation
• Long-Term Disease Course of Pontocerebellar Hypoplasia Type 10
• Molecular Mechanisms in the Design of Novel Targeted Therapies for Neurodegenerative Diseases
• Molecular properties and diagnostic potential of monoclonal antibodies targeting cytotoxic α-synuclein oligomers
• Multidisciplinary care use in neurodegenerative complex diseases: The example of progressive supranuclear palsy and advanced Parkinson's disease in real-life
• Multimodal neuroimaging to characterize symptom-specific networks in movement disorders
• Multiple system atrophy-cerebellar type: Diagnostic challenge in resource-limited settings case report
• Neuropathological findings and in vivo imaging correlates of the red nucleus compared to those of the substantia nigra pars compacta in parkinsonisms
• Neuropathological hallmarks in the post-mortem retina of neurodegenerative diseases
• Ocular Flutter Evoked by Vestibular Stimulation in Multiple System Atrophy with Predominant Cerebellar Ataxia
• Ocular vestibular-evoked myogenic potential assists in differentiation of multiple system atrophy from Parkinson's disease
• On the disease and location specificity of evoked resonant neural activity
• OPA1 promotes ferroptosis by augmenting mitochondrial ROS and suppressing an integrated stress response
• Optic neuropathy from hypovitaminosis A in a series of children with severe dietary restrictions
• Orexin and Sleep Disturbances in Alpha-Synucleinopathies: a Systematic Review
• Pain in Multiple System Atrophy: A Community-Based Survey
• Post-translational Modifications of α-Synuclein, their Therapeutic Potential and Crosstalk in Health and Neurodegenerative Diseases
• Psychiatric Manifestations of Neurological Diseases: A Narrative Review
• Quantitative susceptibility mapping of multiple system atrophy and Parkinson's disease correlates with neurotransmitter reference maps
• Quantitative susceptibility mapping of subcortical iron deposition in Parkinson disease and multiple system atrophy: clinical correlations and diagnostic implications
• Radiomics-Guided Deep Learning Networks Classify Differential Diagnosis of Parkinsonism
• Rational design of structure-based vaccines targeting misfolded alpha-synuclein conformers of Parkinson's disease and related disorders
• Reanalysis of DIA Data Demonstrates the Capabilities of MS/MS-Free Proteomics to Reveal New Biological Insights in Disease-Related Samples
• Residues 2 to 7 of α-synuclein regulate amyloid formation via lipid-dependent and lipid-independent pathways
• Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations in conjunction with systemic lupus erythematosus: Missed diagnosis or misdiagnosis?
• Risk willingness in multiple system atrophy and Parkinson's disease understanding patient preferences
• SNCA and TPPP transcripts increase in oligodendroglial cytoplasmic inclusions in multiple system atrophy
• Structurally targeted mutagenesis identifies key residues supporting alpha -synuclein misfolding in multiple system atrophy
• Structurally targeted mutagenesis identifies key residues supporting alpha-synuclein misfolding in multiple system atrophy
• Tau seeding activity in skin biopsy differentiates tauopathies from synucleinopathies
• The AAV-α-Synuclein Model of Parkinson's Disease: An Update
• The association between cytomegalovirus infection and neurodegenerative diseases: a prospective cohort using UK Biobank data
• The association of vagal atrophy with parameters of autonomic function in multiple system atrophy and progressive supranuclear palsy
• The characteristic and biomarker value of transcranial sonography in cerebellar ataxia
• The Pathobiology of Behavioral Changes in Multiple System Atrophy: An Update
• The recovery of sympathetic skin responses with levodopa in a patient with multiple system atrophy-parkinsonian type
• The Role of Alpha-Synuclein in Synucleinopathy: Impact on Lipid Regulation at Mitochondria-ER Membranes
• The Role of MicroRNAs in Progressive Supranuclear Palsy-A Systematic Review
• Tissue resident memory CD8+ T cells are present but not critical for demyelination and neurodegeneration in a mouse model of multiple system atrophy
• Topical anti-inflammatory treatments for eczema: network meta-analysis
• Treatment-emergent central sleep apnea in a patient with multiple system atrophy: case report
• Two patients of immunotherapy-responsive autoimmune cerebellar ataxia fulfilled with criteria of multiple system atrophy
• Usefulness of Olfactory Bulb Measurement in 3D-FIESTA in Differentiating Parkinson Disease from Atypical Parkinsonism
• White Matter Abnormalities Track Disease Progression in Multiple System Atrophy